Start-ups & Opportunities
OpenAI buys Orchestra Bio to bring AI agents into drug development
OpenAI said on October 20, 2026 it bought San Francisco start-up Orchestra Bio, whose AI agents manage drug development, for its Rosalind life sciences suite.
21 Oct 2026, 07:36 IST